Ayşe Kars
Impact in
- Chemical Health and Safety top 2%
- Occupational Therapy top 5%
- Safe Handling of Antineoplastic Drugs
Papers in
- Oncology 31
- Viral-associated cancers and disorders 7
- Cancer Treatment and Pharmacology 6
-
- Sarcoma Diagnosis and Treatment 9
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Nurşen Başaran (4 shared papers)Dicle Güç (3 shared papers)Gülten Tekuzman (24 shared papers)İbrahim Barışta (25 shared papers)Emin Kansu (18 shared papers)İ. Çelik (19 shared papers)D. Fırat (16 shared papers)Ülkü Ündeğer (3 shared papers)
- Journals
- Acta Oncologica (4 papers)Cancer Investigation (4 papers)Blood (2 papers)Chemotherapy (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- TürkiyeUnited StatesIndia
In The Last Decade
Ayşe Kars
72 papers receiving 740 citations
Peers
Comparison fields: 5 of 100
- Chemical Health and Safety 25
- Occupational Therapy 47
- Otorhinolaryngology 33
- Cancer Research 114
- Pathology and Forensic Medicine 131
Countries citing papers authored by Ayşe Kars
This map shows the geographic impact of Ayşe Kars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Kars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Kars more than expected).
Fields of papers citing papers by Ayşe Kars
This network shows the impact of papers produced by Ayşe Kars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Kars. The network helps show where Ayşe Kars may publish in the future.
Co-authors
The 25 scholars most cited alongside Ayşe Kars, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 71 | |
| 2 | 2006 | 45 | |
| 3 | 1993 | 42 | |
| 4 | 2012 | 35 | |
| 5 | 2000 | 34 | |
| 6 | 1999 | 29 | |
| 7 | 2003 | 28 | |
| 8 | Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. | 1997 | 26 |
| 9 | Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma. | 1996 | 25 |
| 10 | P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. | 1998 | 24 |
| 11 | 2006 | 24 | |
| 12 | 1999 | 21 | |
| 13 | 2002 | 20 | |
| 14 | 1994 | 15 | |
| 15 | 2006 | 15 | |
| 16 | 2002 | 15 | |
| 17 | 1998 | 15 | |
| 18 | 1992 | 14 | |
| 19 | 2002 | 14 | |
| 20 | A questionnaire for the assessment of quality of life in cancer patients in Turkey. | 1997 | 14 |
About Ayşe Kars
Ayşe Kars is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Hematology and Surgery, having authored 73 papers that have together received 770 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Sarcoma Diagnosis and Treatment (9 papers), Multiple Myeloma Research and Treatments (7 papers), Viral-associated cancers and disorders (7 papers), Cancer Treatment and Pharmacology (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Blood disorders and treatments (4 papers). The work is most often cited by research in Chemical Health and Safety (25 citations), Occupational Therapy (47 citations), Otorhinolaryngology (33 citations), Cancer Research (114 citations) and Pathology and Forensic Medicine (131 citations). Ayşe Kars has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Nurşen Başaran, Dicle Güç, Gülten Tekuzman, İbrahim Barışta, Emin Kansu, İ. Çelik, D. Fırat, Ülkü Ündeğer, Hande Canpınar and İbrahim Güllü. Their work appears in journals such as Acta Oncologica, Cancer Investigation, Blood, Chemotherapy and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.